OCD (Ortho-Clinical Diagnostics) claims US first for hepatitis assay
This article was originally published in Clinica
Executive Summary
The US FDA has approved for sale what is claimed to be the first assay for determining immunity to the hepatitis B virus (HBV) using a random access immunoassay analyser.